MAUDE MDR 5243710

MDR report key
5243710
Report number
1049092-2015-00672
Event key
0
Event type
3
Date of event
2015-11-02
Date received
2015-11-23
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
MRS. JEANETTE JOHNSON
Address
DIRECTOR, QUALITY COMPLAINT HANDLING UNIT, 7900 TRIAD CTR DR., STE 400 GREENSBORO, NC 27409 US
Phone
336-336-3365
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1ABVISER INTRA-ABDOMINAL PRESSURE (IAP) MONITORING SYSTEMDEVICE, CYSTOMETRIC, HYDRAULICCONVATECFENABV301130932R N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12015-11-230

Event Narratives#

N

Patient 1

BASED ON THE AVAILABLE INFORMATION, THIS EVENT IS DEEMED A REPORTABLE MALFUNCTION. NO FURTHER INFORMATION WAS AVAILABLE AT THE TIME OF THE REPORT. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED. EXPIRATION DATE: 09/2016. (B)(4).

D

Patient 1

IT WAS REPORTED THE PATIENT WAS ADMITTED WITH A DIAGNOSIS OF ACUTE PANCREATITIS, BILATERAL PLEURAL EFFUSION, ACUTE KIDNEY FAILURE WITH INTRA-ABDOMINAL HYPERTENSION SYMPTOMS. THE CLINICIANS BEGAN MONITORING THE PATIENT'S INTRA-ABDOMINAL PRESSURE VIA AN ABVISER AUTOVALVE IAP MONITORING DEVICE. THE HEALTHCARE PROFESSIONALS CONTINUED WITH THE CLINICAL MANAGEMENT AND PERFORMED A THORACOCENTESIS TO IMPROVE THE PATIENT'S RESPIRATORY PATTERN. FOR THREE DAYS, THE ABVISER WAS FUNCTIONING CORRECTLY, AND HIGH VALUES OF IAP WERE OBSERVED. ON THE FINAL DAY OF USE, THE PATIENT DID NOT ELIMINATE (URINE) "DURING THE SHIFT" AND EXPRESSED SEVERE ABDOMINAL PAIN. IN ADDITION, THERE APPEARED TO BE "A LOT OF SEDIMENT WITHIN THE URINE COLLECTION SYSTEM." THE SYSTEM WAS DISCONNECTED AND THE PATIENT ELIMINATED 1300CC OF URINE. THE ABVISER WAS REMOVED AND REPLACED. WHEN THE AUTOVALVE OF THE OLD ABVISER WAS INSPECTED BY THE FACILITY, THE MEMBRANE WAS REPORTED "INFLATED" AND WAS "BLOCKING THE SYSTEM'S VENT." NO FURTHER PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT.

N

Patient 1

ADDITIONAL INFORMATION: SALINE SOLUTION 0.9% WAS THE TYPE OF INFUSION FLUID THAT WAS USED BY THE CLINICIAN TO OPERATE THE DEVICE. IT WAS 4 HOURS IN BETWEEN SHIFT WHEN THE DEVICE WAS KNOWN TO BE OPERATING PROPERLY AND WHEN THE NURSE FOUND THE AUTOVALVE NOT FUNCTIONING PROPERLY. NO FURTHER INFORMATION WAS AVAILABLE AT THE TIME OF THE REPORT. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

N

Patient 1

ADDITIONAL INFORMATION: SIX MONTHS OF HISTORICAL BATCH RECORDS WHICH WERE MANUFACTURED FROM THE BEGINNING OF APRIL 2015 TO THE END OF SEPTEMBER, 2015, WERE REVIEWED AND ALL SHOWED THAT ALL SAMPLES SUBJECTED TO THE OPERATIONAL TIMING TEST FOR THE AUTOVALVE MET THE SPECIFICATION FOR OPERATIONAL TIMING OF 90 SECONDS (-30 SECONDS TO + 90 SECONDS). WITH THE AUTOVALVE DISCARDED BY THE END USER, IT WAS NOT AVAILABLE FOR PHYSICAL ANALYSIS TO DETERMINE THE POTENTIAL ROOT CAUSE. FROM THE EXAMINATION OF THE PHOTO, HISTORY AND COMPLAINT DESCRIPTION, THE POTENTIAL REASON WAS THAT THE AUTOVALVE MAY HAVE BEEN OCCLUDED. NO PREVIOUS INVESTIGATIONS ARE AVAILABLE. AFTER REVIEW OF THE RETURNED AND DETAILED SIX MONTH BATCH REVIEW, NO DISCREPANCIES WERE FOUND. THERE IS NOT ENOUGH INFORMATION TO CONCLUDE THE PRODUCT DID NOT MEET SPECIFICATION AND PERFORM AS INTENDED. PRODUCT MONITORING REVIEWS WILL MONITOR FOR PRODUCT TRENDS IF THIS ISSUE WERE TO REOCCUR. NO FURTHER ACTIONS ARE REQUIRED, AND THE COMPLAINT WILL BE CLOSED. NO ADDITIONAL PATIENT/EVENT DETAILS HAVE BEEN PROVIDED TO DATE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE A FOLLOW-UP REPORT WILL BE SUBMITTED. (B)(4).

N

Patient 1

NO ADDITIONAL PATIENT/EVENT DETAILS HAVE BEEN PROVIDED TO DATE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED. (B)(4).